
No. of Pages: 131 | Report Code: BMIRE00029047 | Category: Life Sciences
No. of Pages: 131 | Report Code: BMIRE00029047 | Category: Life Sciences
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Lung Cancer Screening Market – by Technology
1.3.2 Europe Lung Cancer Screening Market – by Cancer Type
1.3.3 Europe Lung Cancer Screening Market – by Age Group
1.3.4 Europe Lung Cancer Screening Market – by End User
1.3.5 Europe Lung Cancer Screening Market – by Country
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4.1 Overview
4.2 Europe PEST Analysis
4.3 Expert’s Opinion
5.1 Market Drivers
5.1.1 Rising Lung Cancer Incidences
5.2 Market Restraints
5.2.1 High Cost of Lung Cancer Screening Tests
5.3 Market Opportunities
5.3.1 Structured Lung Cancer Screening Program
5.4 Future Trends
5.4.1 Mobile Lung Cancer Screening Truck
5.5 Impact Analysis
6.1 Europe Lung Cancer Screening Market Revenue Forecast and Analysis
7.1 Overview
7.2 Europe Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)
7.3 Non–Small Cell Lung Cancer (NSCLC)
7.3.1 Overview
7.3.2 Non–Small Cell Lung Cancer (NSCLC): Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Mn)
7.4 Small Cell Lung Cancer
7.4.1 Overview
7.4.2 Small Cell Lung Cancer: Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
8.1 Overview
8.2 Low-Dose Computed Tomography (LDCT)
8.2.1 Overview
8.2.2 Low-Dose Computed Tomography (LDCT): Europe Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)
8.3 Chest X-ray
8.3.1 Overview
8.3.2 Chest X-ray: Europe Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)
8.4 Liquid Biopsy
8.4.1 Overview
8.4.2 Liquid Biopsy: Europe Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Europe Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)
9.1 Overview
9.2 & Older
9.2.1 Overview
9.2.2 & Older: Australia Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Below 50
9.3.1 Overview
9.3.2 Below 50: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)
10.1 Overview
10.2 Hospitals
10.2.1 Overview
10.2.2 Hospitals: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)
10.3 Diagnostic Centers
10.3.1 Overview
10.3.2 Diagnostic Centers: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Others
10.4.1 Overview
10.4.2 Others: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)
11.1 Europe: Europe Lung Cancer Screening Market Overview
11.1.1.1 Germany: Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.1.1 Overview
11.1.1.1.2 Germany: Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.1.3 Germany: Europe Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.1.1.1.4 Germany: Europe Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
11.1.1.1.5 Germany: Europe Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.1.1.1.6 Germany: Europe Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.1.1.2 UK: Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.2.1 Overview
11.1.1.2.2 UK: Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.2.3 UK: Europe Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.1.1.2.4 UK: Europe Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
11.1.1.2.5 UK: Europe Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.1.1.2.6 UK: Europe Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.1.1.3 France: Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.3.1 Overview
11.1.1.3.2 France: Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.3.3 France: Europe Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.1.1.3.4 France: Europe Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
11.1.1.3.5 France: Europe Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.1.1.3.6 France: Europe Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.1.1.4 Italy: Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.4.1 Overview
11.1.1.4.2 Italy: Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.4.3 Italy: Europe Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.1.1.4.4 Italy: Europe Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
11.1.1.4.5 Italy: Europe Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.1.1.4.6 Italy: Europe Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.1.1.5 Spain: Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.5.1 Overview
11.1.1.5.2 Spain: Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.5.3 Spain: Europe Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.1.1.5.4 Spain: Europe Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
11.1.1.5.5 Spain: Europe Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.1.1.5.6 Spain: Europe Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.1.1.6 Rest of Europe: Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.6.1 Overview
11.1.1.6.2 Rest of Europe: Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.6.3 Rest of Europe: Europe Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.1.1.6.4 Rest of Europe: Europe Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
11.1.1.6.5 Rest of Europe: Europe Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.1.1.6.6 Rest of Europe: Europe Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
12.1 Recent Growth Strategies
12.1.1 Overview
13.1 Intelerad Medical Systems
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Nuance Communications Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 GE HealthCare
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Medtronic
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Canon Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Koninklijke Philips NV
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Siemens AG
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
14.1 About The Insight Partners
14.2 Glossary of Terms
Table 1. Germany Europe Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)
Table 2. Germany Europe Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 3. Germany Europe Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 4. Germany Europe Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 5. UK Europe Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)
Table 6. UK Europe Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 7. UK Europe Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 8. UK Europe Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 9. France Europe Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)
Table 10. France Europe Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 11. France Europe Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 12. France Europe Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 13. Italy Europe Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)
Table 14. Italy Europe Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 15. Italy Europe Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 16. Italy Europe Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 17. Spain Europe Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)
Table 18. Spain Europe Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 19. Spain Europe Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 20. Spain Europe Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 21. Rest of Europe Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)
Table 22. Rest of Europe Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 23. Rest of Europe Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 24. Rest of Europe Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 25. Recent Growth Strategies in the Europe Lung Cancer Screening Market
Table 26. Glossary of Terms
Figure 1. Europe Lung Cancer Screening Market Segmentation
Figure 2. Europe Lung Cancer Screening Market, by Country
Figure 3. Europe Lung Cancer Screening Market Overview
Figure 4. Non-Small Cell Lung Cancer Segment Held Largest Share of Cancer Type Segment in Europe Lung Cancer Screening Market
Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period
Figure 6. Europe: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. Europe Lung Cancer Screening Market Impact Analysis of Driver and Restraints
Figure 9. Europe Lung Cancer Screening Market – Revenue Forecast and Analysis – 2020-2030
Figure 10. Europe Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)
Figure 11. Non–Small Cell Lung Cancer (NSCLC): Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Small Cell Lung Cancer: Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Europe Lung Cancer Screening Market, by Technology, 2022 & 2030 (%)
Figure 14. Low-Dose Computed Tomography (LDCT): Europe Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)
Figure 15. Chest X-ray: Europe Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)
Figure 16. Liquid Biopsy: Europe Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Europe Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)
Figure 18. Europe Lung Cancer Screening Market, by Age group, 2022 & 2030 (%)
Figure 19. & Older: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Below 50: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Europe Lung Cancer Screening Market, by End User, 2022 & 2030 (%)
Figure 22. Hospitals: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Diagnostic Centers: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Others: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Europe Lung Cancer Screening Market, by Key Country – Revenue (2022) (US$ Million)
Figure 26. Europe Lung Cancer Screening Market Revenue Share, by Country, (2022 & 2030)
Figure 27. Germany: Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. UK: Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. France: Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 30. Italy: Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. Spain: Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 32. Rest of Europe: Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)